Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew J. Perlman
Andrew J. Perlman
Medicine
Placebo
Serlopitant
Internal medicine
Dermatology
4
Papers
123
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
2019
Journal of The American Academy of Dermatology
Sonja Ständer
Paul Kwon
Joe Hirman
Andrew J. Perlman
Elke Weisshaar
Martin Metz
Thomas A. Luger
Show All
Source
Cite
Save
Citations (54)
Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial
2018
Journal of The American Academy of Dermatology
Gil Yosipovitch
Sonja Ständer
Matthew B. Kerby
James W. Larrick
Andrew J. Perlman
Edward F. Schnipper
Xiaoming Zhang
Jean Y. Tang
Thomas A. Luger
Martin Steinhoff
Show All
Source
Cite
Save
Citations (69)
Iconography : Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial
2018
Journal of The American Academy of Dermatology
Gil Yosipovitch
Sonja Ständer
Matthew B. Kerby
James W. Larrick
Andrew J. Perlman
Edward F. Schnipper
Xiaoming Zhang
Jean Y. Tang
Thomas A. Luger
Martin Steinhoff
Show All
Source
Cite
Save
Citations (0)
Utilisation de serlopitant, antagoniste du récepteur nk -1, dans le traitement du prurit
2014
Xiaoming Zhang
Edward F. Schnipper
Andrew J. Perlman
James W. Larrick
Show All
Source
Cite
Save
Citations (0)
1